What side effects are associated with this type of intervention?

The most common treatments for cardiac arrest, including CPR, defibrillation, and ACLS medications, can have several side effects. CPR can cause physical injuries such as rib fractures and internal organ damage. Defibrillation may result in burns or skin irritation. ACLS medications can lead to adverse reactions like arrhythmias, hypotension, or allergic responses. These side effects are important to consider, especially in specialized resuscitation programs like the Obstetric Life Support Program, which aims to improve outcomes in pregnant patients experiencing cardiac arrest.

What prior FDA approvals exist?

FDA-approved treatments for cardiac arrest typically include the use of medications such as epinephrine and amiodarone, which are administered during advanced cardiac life support (ACLS) protocols. These drugs help to restore heart rhythm and improve survival rates. The Obstetric Life Support Program focuses on educational training to enhance the confidence and skills of healthcare providers in resuscitating pregnant patients experiencing cardiac arrest, emphasizing the importance of timely and effective intervention.

What other types of research exist?

Promising alternatives to the Obstetric Life Support Program for improving confidence and skills knowledge in managing cardiac arrest in obstetric patients include simulation-based training, virtual reality (VR) and augmented reality (AR) platforms, telementoring, and advanced automated external defibrillators (AEDs) with real-time feedback.

← Back to Search

Behavioural Intervention

Obstetric Life Support Training for Cardiac Arrest in Pregnant Patients (OBLS Trial)

N/A

Waitlist Available

Led By Andrea Shields, MD

Research Sponsored by UConn Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from baseline to 6 months

Summary

This trial aims to see if the Obstetric Life Support Program (OBLS) can improve the confidence and skills of healthcare professionals. The program includes online lessons and hands-on training. Participants will be assessed at different stages to measure any improvements. The Obstetric Life Support (ObLS) training program is a method of obstetric nursing and medical staff training that is relevant, comprehensive, and cost-effective.

Who is the study for?

This trial is for EMS providers, firefighters, law enforcement officers, emergency medicine providers, surgeons (OB), anesthesiologists, and nurses in specific departments. Participants must be at least 18 years old and able to communicate in English. Those involved in pilot-testing or from other medical specialties are excluded.

What is being tested?

The study is testing the Obstetric Life Support Program's impact on confidence and skills knowledge of healthcare professionals. It involves an electronic curriculum with instructor-led courses compared against a placebo approach.

What are the potential side effects?

Since this trial focuses on educational content rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience stress or fatigue due to learning new material.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from baseline to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from baseline to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change from Baseline in the Mean Participant Knowledge Assessment

Comparison of Scores Between Two Arms

Secondary study objectives

Self-Reported Confidence Level in Assessing and Managing Critical Care Scenarios in Pregnant Patients

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Curriculum and Instructor-Led CourseActive Control1 Intervention

Participants first complete an online cognitive assessment. Once complete, staff email the electronic curriculum for participants to read. On a specific day, participants will go to the designated center to participate in an instructor-led course and simulated medical scenarios and complete megapode and online cognitive assessment. After a washout period of six months, participants return to the designated center to participate in simulated medical scenarios and complete the online cognitive assessment again. After a second washout period of six months, participants will take the online cognitive assessment again.

Group II: PlaceboPlacebo Group1 Intervention

On a specific day, participants will go to a designated center to complete an online cognitive assessment and participate in simulated medical scenarios. Once complete, study staff will email the electronic curriculum for participants to read. After a washout period of six months, participants will return to the designated center to participate in an instructor-led course and simulated medical scenarios and complete a megapode and online cognitive assessment. After a second washout period of six months, participants will take an online cognitive assessment again.

Do I qualify?Apply below to find out

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

The most common treatments for cardiac arrest include cardiopulmonary resuscitation (CPR), defibrillation, and the administration of medications like epinephrine. CPR maintains circulation and oxygenation to vital organs through manual chest compressions, which is crucial for sustaining life until more definitive treatments can be applied. Defibrillation delivers an electric shock to the heart to restore a normal rhythm in cases of ventricular fibrillation or pulseless ventricular tachycardia. Epinephrine increases coronary and cerebral perfusion pressure, improving the chances of return of spontaneous circulation (ROSC). These interventions are vital as they address the immediate life-threatening aspects of cardiac arrest, providing a bridge to more advanced care and improving survival rates.

Educational polymorphisms of basic life support algorithms.